The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The study authors said the research is among the first to explore how the enormous nationwide spike in …

This post was originally published on this site